Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-02-02

Clinical Trial Update: Assessing Physical Function in Sickle Cell Patients Taking Voxelotor [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating the impact of voxelotor on physical function in patients with Sickle Cell Disease and is currently active but not recruit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Oxbryta (voxelotor)

Snippet

Sponsor: Inova Health Care Services | Conditions: Sickle Cell Disease | Phase 2 | Status: ACTIVE_NOT_RECRUITING